354 related articles for article (PubMed ID: 27664137)
1. The Role of Long Non-Coding RNAs in Ovarian Cancer.
Nikpayam E; Tasharrofi B; Sarrafzadeh S; Ghafouri-Fard S
Iran Biomed J; 2017 Jan; 21(1):3-15. PubMed ID: 27664137
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of lncRNA-mRNA co-expression patterns identifies immune-associated lncRNA biomarkers in ovarian cancer malignant progression.
Guo Q; Cheng Y; Liang T; He Y; Ren C; Sun L; Zhang G
Sci Rep; 2015 Dec; 5():17683. PubMed ID: 26631459
[TBL] [Abstract][Full Text] [Related]
3. Long Non-Coding RNAs: the New Horizon of Gene Regulation in Ovarian Cancer.
Worku T; Bhattarai D; Ayers D; Wang K; Wang C; Rehman ZU; Talpur HS; Yang L
Cell Physiol Biochem; 2017; 44(3):948-966. PubMed ID: 29179183
[TBL] [Abstract][Full Text] [Related]
4. The long non-coding RNA CCAT2 is up-regulated in ovarian cancer and associated with poor prognosis.
Huang S; Qing C; Huang Z; Zhu Y
Diagn Pathol; 2016 Jun; 11(1):49. PubMed ID: 27283598
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of the long non-coding RNA SPRY4-IT1 indicates a poor prognosis and promotes tumorigenesis in ovarian cancer.
Li H; Liu C; Lu Z; Chen L; Wang J; Li Y; Ma H
Biomed Pharmacother; 2017 Apr; 88():529-534. PubMed ID: 28129625
[TBL] [Abstract][Full Text] [Related]
6. Expression of long noncoding RNAs in cancer-associated fibroblasts linked to patient survival in ovarian cancer.
Colvin EK; Howell VM; Mok SC; Samimi G; Vafaee F
Cancer Sci; 2020 May; 111(5):1805-1817. PubMed ID: 32058624
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA HOTTIP is a significant indicator of ovarian cancer prognosis and enhances cell proliferation and invasion.
Zou T; Wang PL; Gao Y; Liang WT
Cancer Biomark; 2019; 25(2):133-139. PubMed ID: 30452402
[TBL] [Abstract][Full Text] [Related]
8. Clinical prospects of long noncoding RNAs as novel biomarkers and therapeutic targets in prostate cancer.
Mouraviev V; Lee B; Patel V; Albala D; Johansen TE; Partin A; Ross A; Perera RJ
Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):14-20. PubMed ID: 26503110
[TBL] [Abstract][Full Text] [Related]
9. Cox-LASSO Analysis Reveals a Ten-lncRNA Signature to Predict Outcomes in Patients with High-Grade Serous Ovarian Cancer.
Xu L; Wu Y; Che X; Zhao J; Wang F; Wang P; Qu X; Liu Y; Li Z
DNA Cell Biol; 2019 Dec; 38(12):1519-1528. PubMed ID: 31657627
[TBL] [Abstract][Full Text] [Related]
10. Functional prediction of long non-coding RNAs in ovarian cancer-associated fibroblasts indicate a potential role in metastasis.
Vafaee F; Colvin EK; Mok SC; Howell VM; Samimi G
Sci Rep; 2017 Sep; 7(1):10374. PubMed ID: 28871211
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA and Long Non-Coding RNA in Ovarian Carcinoma: Translational Insights and Potential Clinical Applications.
Ma Y; Lu Y; Lu B
Cancer Invest; 2016 Oct; 34(9):465-476. PubMed ID: 27673409
[TBL] [Abstract][Full Text] [Related]
12. LncRNAs: emerging biomarkers in gastric cancer.
Gu Y; Chen T; Li G; Yu X; Lu Y; Wang H; Teng L
Future Oncol; 2015; 11(17):2427-41. PubMed ID: 26289363
[TBL] [Abstract][Full Text] [Related]
13. A panel of 7 prognosis-related long non-coding RNAs to improve platinum-based chemoresistance prediction in ovarian cancer.
Song J; Zhang W; Wang S; Liu K; Song F; Ran L
Int J Oncol; 2018 Aug; 53(2):866-876. PubMed ID: 29749482
[TBL] [Abstract][Full Text] [Related]
14. Identification of pathological grade and prognosis-associated lncRNA for ovarian cancer.
Chen Y; Bi F; An Y; Yang Q
J Cell Biochem; 2019 Sep; 120(9):14444-14454. PubMed ID: 31034644
[TBL] [Abstract][Full Text] [Related]
15. Identification of differentially expressed signatures of long non-coding RNAs associated with different metastatic potentials in gastric cancer.
Song W; Liu YY; Peng JJ; Liang HH; Chen HY; Chen JH; He WL; Xu JB; Cai SR; He YL
J Gastroenterol; 2016 Feb; 51(2):119-29. PubMed ID: 26045391
[TBL] [Abstract][Full Text] [Related]
16. Construction and analysis of lncRNA-lncRNA synergistic networks to reveal clinically relevant lncRNAs in cancer.
Li Y; Chen J; Zhang J; Wang Z; Shao T; Jiang C; Xu J; Li X
Oncotarget; 2015 Sep; 6(28):25003-16. PubMed ID: 26305674
[TBL] [Abstract][Full Text] [Related]
17. An overview of long non-coding RNAs in ovarian cancers.
Meryet-Figuière M; Lambert B; Gauduchon P; Vigneron N; Brotin E; Poulain L; Denoyelle C
Oncotarget; 2016 Jul; 7(28):44719-44734. PubMed ID: 26992233
[TBL] [Abstract][Full Text] [Related]
18. Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes.
Tripathi MK; Doxtater K; Keramatnia F; Zacheaus C; Yallapu MM; Jaggi M; Chauhan SC
Drug Discov Today; 2018 Sep; 23(9):1635-1643. PubMed ID: 29698834
[TBL] [Abstract][Full Text] [Related]
19. A long noncoding RNA AB073614 promotes tumorigenesis and predicts poor prognosis in ovarian cancer.
Cheng Z; Guo J; Chen L; Luo N; Yang W; Qu X
Oncotarget; 2015 Sep; 6(28):25381-9. PubMed ID: 26299803
[TBL] [Abstract][Full Text] [Related]
20. Metastasis-associated long noncoding RNAs in gastrointestinal cancer: Implications for novel biomarkers and therapeutic targets.
Zhang FF; Luo YH; Wang H; Zhao L
World J Gastroenterol; 2016 Oct; 22(39):8735-8749. PubMed ID: 27818589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
